+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "CAS9"

From
CRISPR Technology: Global Markets - Product Thumbnail Image

CRISPR Technology: Global Markets

  • Report
  • January 2023
  • 131 Pages
  • Global
From
Cell and Gene Therapy (CGT) Growth Opportunities - Product Thumbnail Image

Cell and Gene Therapy (CGT) Growth Opportunities

  • Report
  • September 2022
  • 94 Pages
  • Global
From
Technology Growth Opportunities for Exosome-Mediated Drug Delivery - Product Thumbnail Image

Technology Growth Opportunities for Exosome-Mediated Drug Delivery

  • Report
  • September 2022
  • 62 Pages
  • Global
From
From
Crispr Technology Market 2022-2026 - Product Thumbnail Image

Crispr Technology Market 2022-2026

  • Report
  • May 2022
  • Global
From
Gene Synthesis Services Market 2022-2026 - Product Thumbnail Image

Gene Synthesis Services Market 2022-2026

  • Report
  • April 2022
  • 120 Pages
  • Global
From
From
From
UAE Gene Therapy Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

UAE Gene Therapy Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • February 2025
  • 85 Pages
  • United Arab Emirates United Arab Emirates
From
From
UAE Genetic Testing Market, By Region, Competition, Forecast & Opportunities, 2019-2029F - Product Thumbnail Image

UAE Genetic Testing Market, By Region, Competition, Forecast & Opportunities, 2019-2029F

  • Report
  • October 2024
  • 75 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
Loading Indicator

The CAS9 market is a subset of the genomics industry that focuses on the development and use of the CRISPR-Cas9 gene-editing technology. This technology is used to modify the genetic code of living organisms, allowing for the manipulation of genes and the potential to create new treatments for diseases. CAS9 is a powerful tool for researchers, allowing them to make precise changes to the genetic code of organisms. The CAS9 market is growing rapidly, with many companies investing in the technology and its applications. Companies such as Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences are leading the way in developing and commercializing the technology. Other companies such as Horizon Discovery, Synthego, and Twist Bioscience are also investing in the CAS9 market, providing tools and services to researchers. Show Less Read more